Immunodeficiency
35
9
11
15
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.4%
4 terminated out of 35 trials
78.9%
-7.6% vs benchmark
14%
5 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (35)
Genetic Analysis of Immune Disorders
Vaccine-induced Immunity in Immunocompromised Patients
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
The Sequestration of Holistic Stress Management Techniques for Adults
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
Clozapine-related Immunodeficiency in Parkinsons Disease
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Blood Samples to Identify Biomarkers of Busulfan
Expanded Access Protocol Thymus Transplantation
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients
PREP (Pre-Exposure Prophylaxis) of COVID-19